289 related articles for article (PubMed ID: 30101525)
1. Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth.
Thijssen VL; Paulis YW; Nowak-Sliwinska P; Deumelandt KL; Hosaka K; Soetekouw PM; Cimpean AM; Raica M; Pauwels P; van den Oord JJ; Tjan-Heijnen VC; Hendrix MJ; Heldin CH; Cao Y; Griffioen AW
J Pathol; 2018 Dec; 246(4):447-458. PubMed ID: 30101525
[TBL] [Abstract][Full Text] [Related]
2. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
3. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
Ruan J; Luo M; Wang C; Fan L; Yang SN; Cardenas M; Geng H; Leonard JP; Melnick A; Cerchietti L; Hajjar KA
Blood; 2013 Jun; 121(26):5192-202. PubMed ID: 23632889
[TBL] [Abstract][Full Text] [Related]
4. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
Siedlecki J; Wertheimer C; Wolf A; Liegl R; Priglinger C; Priglinger S; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):963-972. PubMed ID: 28161830
[TBL] [Abstract][Full Text] [Related]
5. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
Keskin D; Kim J; Cooke VG; Wu CC; Sugimoto H; Gu C; De Palma M; Kalluri R; LeBleu VS
Cell Rep; 2015 Feb; 10(7):1066-81. PubMed ID: 25704811
[TBL] [Abstract][Full Text] [Related]
6. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Pietras K; Pahler J; Bergers G; Hanahan D
PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
[TBL] [Abstract][Full Text] [Related]
7. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.
Semela D; Das A; Langer D; Kang N; Leof E; Shah V
Gastroenterology; 2008 Aug; 135(2):671-9. PubMed ID: 18570897
[TBL] [Abstract][Full Text] [Related]
9. The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.
Robinson SP; Ludwig C; Paulsson J; Ostman A
Int J Cancer; 2008 Apr; 122(7):1548-56. PubMed ID: 18033683
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
11. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression.
Bhattacharyya S; Mitra D; Ray S; Biswas N; Banerjee S; Majumder B; Mustafi SM; Murmu N
Microvasc Res; 2019 Jan; 121():52-62. PubMed ID: 30381268
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
[TBL] [Abstract][Full Text] [Related]
13. PARP inhibition promotes endothelial-like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry.
Fernández-Cortés M; Delgado-Bellido D; Bermúdez-Jiménez E; Paramio JM; O'Valle F; Vinckier S; Carmeliet P; Garcia-Diaz A; Oliver FJ
J Pathol; 2023 Mar; 259(3):318-330. PubMed ID: 36484652
[TBL] [Abstract][Full Text] [Related]
14. Uveal Melanoma Cells Elicit Retinal Pericyte Phenotypical and Biochemical Changes in an in Vitro Model of Coculture.
Anfuso CD; Longo A; Distefano A; Amorini AM; Salmeri M; Zanghì G; Giallongo C; Giurdanella G; Lupo G
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756477
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
Song N; Huang Y; Shi H; Yuan S; Ding Y; Song X; Fu Y; Luo Y
Cancer Res; 2009 Aug; 69(15):6057-64. PubMed ID: 19584297
[TBL] [Abstract][Full Text] [Related]
17. Defining Endothelial Cell-Derived Factors That Promote Pericyte Recruitment and Capillary Network Assembly.
Kemp SS; Aguera KN; Cha B; Davis GE
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2632-2648. PubMed ID: 32814441
[TBL] [Abstract][Full Text] [Related]
18. Combined VEGF/PDGF inhibition using axitinib induces αSMA expression and a pro-fibrotic phenotype in human pericytes.
Siedlecki J; Asani B; Wertheimer C; Hillenmayer A; Ohlmann A; Priglinger C; Priglinger S; Wolf A; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1141-1149. PubMed ID: 29721663
[TBL] [Abstract][Full Text] [Related]
19. Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors.
Sennino B; Kuhnert F; Tabruyn SP; Mancuso MR; Hu-Lowe DD; Kuo CJ; McDonald DM
Cancer Res; 2009 May; 69(10):4527-36. PubMed ID: 19401451
[TBL] [Abstract][Full Text] [Related]
20. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis.
Hosaka K; Yang Y; Seki T; Nakamura M; Andersson P; Rouhi P; Yang X; Jensen L; Lim S; Feng N; Xue Y; Li X; Larsson O; Ohhashi T; Cao Y
Nat Commun; 2013; 4():2129. PubMed ID: 23831851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
